Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing oxcarbazepine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Oxcarbazepine (substance) |
Inferred relationship |
Some |
1 |
Oxcarbazepine 150 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxcarbazepine (substance) |
Inferred relationship |
Some |
|
Oxcarbazepine 300 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxcarbazepine (substance) |
Inferred relationship |
Some |
|
Oxcarbazepine 600 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxcarbazepine (substance) |
Inferred relationship |
Some |
|
Oxcarbazepine 300mg/5 mL oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxcarbazepine (substance) |
Inferred relationship |
Some |
|
Oxcarbazepine 60mg/mL s/f oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxcarbazepine (substance) |
Inferred relationship |
Some |
|
Quantitative measurement of mass concentration of oxcarbazepine in serum or plasma specimen (procedure) |
Component |
False |
Oxcarbazepine (substance) |
Inferred relationship |
Some |
2 |
10-hydroxycarbazepine (substance) |
Is a |
False |
Oxcarbazepine (substance) |
Inferred relationship |
Some |
|
Oxcarbazepine 150 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxcarbazepine (substance) |
Inferred relationship |
Some |
1 |
Oxcarbazepine 150 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Oxcarbazepine (substance) |
Inferred relationship |
Some |
1 |
Oxcarbazepine 300 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxcarbazepine (substance) |
Inferred relationship |
Some |
1 |
Oxcarbazepine 300 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Oxcarbazepine (substance) |
Inferred relationship |
Some |
1 |
Oxcarbazepine 600 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxcarbazepine (substance) |
Inferred relationship |
Some |
1 |
Oxcarbazepine 600 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Oxcarbazepine (substance) |
Inferred relationship |
Some |
1 |
Oxcarbazepine 150 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Oxcarbazepine (substance) |
Inferred relationship |
Some |
1 |
Oxcarbazepine 300 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Oxcarbazepine (substance) |
Inferred relationship |
Some |
1 |
Oxcarbazepine 600 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Oxcarbazepine (substance) |
Inferred relationship |
Some |
1 |
Oxcarbazepine 60 mg/mL oral suspension |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Oxcarbazepine (substance) |
Inferred relationship |
Some |
1 |
Oxcarbazepine 60 mg/mL oral suspension |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Oxcarbazepine (substance) |
Inferred relationship |
Some |
1 |
Product containing oxcarbazepine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Oxcarbazepine (substance) |
Inferred relationship |
Some |
1 |
Product containing only oxcarbazepine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Oxcarbazepine (substance) |
Inferred relationship |
Some |
1 |
Product containing only oxcarbazepine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Oxcarbazepine (substance) |
Inferred relationship |
Some |
1 |
Quantitative measurement of mass concentration of oxcarbazepine in serum or plasma specimen (procedure) |
Component |
True |
Oxcarbazepine (substance) |
Inferred relationship |
Some |
1 |